PubMed · 8833387
Primary chemotherapy: how does it compare with surgery?
Abstract
Small-volume metastatic nonseminoma primary chemotherapy following orchidectomy cures the same high proportion of patients as does retroperitoneal lymph node dissection (RPLND). The 5-year survival in 122 patients treated at the Royal Marsden Hospital was 97%; 35 of these men had postchemotherapy lymphadenectomy and only 5 suffered loss of ejaculation. Primary chemotherapy is a reasonable alternative to RPLND for stage II testicular nonseminoma.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
A Horwich. 1996. Primary chemotherapy: how does it compare with surgery?. https://pubmed.ncbi.nlm.nih.gov/8833387/
Cite the original work for its findings. Save a collection to share your selection of sources.